Close

Needham & Company Reiterates Buy Rating on I-Mab (IMAB)

March 29, 2022 2:13 PM EDT Send to a Friend
Needham & Company analyst Gil Blum reiterated a Buy rating and $85.00 price target on I-Mab (NASDAQ: IMAB).The analyst quotes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login